SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
Microsoft is preparing a major Windows 11 reliability update for May 2026 with improvements across File Explorer, ...
China NMPA approves GSK’s Blenrep for treatment of 2L+ relapsed/refractory multiple myeloma: London, UK Tuesday, April 21, 2026, 10:00 Hrs [IST] GSK plc announced the National M ...
A new vulnerability dubbed Pack2TheRoot could be exploited in the PackageKit daemon to allow local Linux users to install or ...
ZenaTech scales Drone-as-a-Service via acquisitions, boosting recurring revenue 1,225% YoY. Read why I rate ZENA stock a Buy ...
The government plans to cut the number of NDIS users by 160,000 over the next four years. Here’s what we know about how they’ll do that and who’ll be affected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results